| Name
|
Elcatonin
|
| Code
|
|
| The alias
|
Elcatonin
|
| Sequence (single letter abbreviation)
|
SNLST-Asu-VLGKLSQELHKLQTYPRTDVGAGTP-NH2?(Peptide bond Ser1 and Asu6 bridge)
|
| Sequence (three-letter abbreviation)
|
H-Ser-Asn-Leu-Ser-Thr-Asu-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH2(trifluoroacetate salt)(Peptide bond Ser1 and Asu6 bridge)
|
| A basic description
|
Inhibitor of gastrin and gastric acid secretion that leads to a lowering of plasma calcium and phosphate levels by inhibiting bone reabsorption and excretion through the kidneys.
|
| solubility
|
|
| The molecular weight
|
3363.9
|
| Chemical formula
|
C147H242N42O47
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
A. Caniggia et al., Minerva Medica , 74, 993 (1983)
Italian Osteoporosis Network, Current Therapeutic Res., 45, 502 (1989)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
(Peptide bond Ser1 and Asu6 bridge)
|